Table 2.

Case reports involving the use of tocilizumab in patients with COVID-19.

Author (Year)	Country	Age	Sex	Chronic illness	Symptoms	Bilateral patchy groundglass opacities due to COVID-19	Mechanical ventilation	TCZ dosing	Death	Recovered
Ferrey (2020)	United States	56	M	ESRD, CAD, CMOP	Cough, fever, N/V, SOB, diarrhea, myalgias, afib, ARDS	Yes	Yes	NR	No	Unknown
Michot (2020)	France	42	M	mCCRCC	Cough, fever, SOB	Yes	No	8 mg/kg IV x 2 doses	No	Yes
Mihai (2020)	Switzerland	57	F	SSc-ILD, T2DM, obesity	Cough, headache, malaise	No	No	8 mg/kg IV every 4 weeks x 3 years	No	Yes
Zhang (2020)	China	60	M	MM	Chest tightness, SOB	Yes	No	8 mg/kg IV x 1 dose	No	Yes

Abbreviations: afib: atrial fibrillation; ARDS: acute respiratory distress syndrome; CAD: coronary artery disease; CMOP: cardiomyopathy; ESRD: end-stage renal disease; F: female; IV: intravenous; N/V: nausea and vomiting; NR: not reported; M: male; mCCRCC: metastatic clear cell renal cell carcinoma; MM: multiple myeloma; SOB: shortness of breath; SSc-ILD: systemic sclerosis with interstitial lung disease; T2DM: type II diabetes mellitus; TCZ: tocilizumab.